NRX Pharmaceuticals Analyst Ratings
Buy Rating Affirmed for NRX Pharmaceuticals Amid Promising Outlook for Novel Depression Treatment NRX-100
Analysts Are Bullish on These Healthcare Stocks: HCA Healthcare (HCA), NRX Pharmaceuticals (NRXP)
H.C. Wainwright Sticks to Their Buy Rating for NRX Pharmaceuticals (NRXP)
HC Wainwright & Co. Reiterates Buy on NRX Pharmaceuticals, Maintains $2 Price Target
Ascendiant Remains a Buy on NRX Pharmaceuticals (NRXP)
H.C. Wainwright Sticks to Their Buy Rating for NRX Pharmaceuticals (NRXP)
NRX Pharmaceuticals Analyst Ratings
HC Wainwright & Co. Reiterates Buy on NRX Pharmaceuticals, Maintains $2 Price Target
H.C. Wainwright Remains a Buy on NRX Pharmaceuticals (NRXP)
Analysts Offer Insights on Healthcare Companies: NRX Pharmaceuticals (NRXP) and Arcutis Biotherapeutics (ARQT)
NRX Pharmaceuticals Analyst Ratings
Ascendiant Capital Initiates Coverage On NRX Pharmaceuticals With Buy Rating, Announces Price Target of $4
H.C. Wainwright Sticks to Their Buy Rating for NRX Pharmaceuticals (NRXP)
HC Wainwright Starts NRX Pharmaceuticals at Buy With $2 Price Target
NRX Pharmaceuticals Price Target Announced at $2.00/Share by HC Wainwright & Co.
NRX Pharmaceuticals Initiated at Buy by HC Wainwright & Co.
Analysts Offer Insights on Healthcare Companies: Aileron Therapeutics (ALRN), NRX Pharmaceuticals (NRXP) and Cybin (CYBN)
NRX Pharmaceuticals analyst ratings